Reference
Cost-effectiveness of bezlotoxumab for the prevention of recurrence of Clostridium difficile infection in Spain 28th European Congress of Clinical Microbiology and Infectious Diseases : 24 Apr 2018. Available from: URL: http://www.eccmidlive.org/#resources/cost-effectiveness-of-bezlotoxumab-for-the-prevention-of-recurrence-of-clostridium-difficile-infection-in-spain
Rights and permissions
About this article
Cite this article
Bezlotoxumab cost effective for C. difficile infection. PharmacoEcon Outcomes News 804, 7 (2018). https://doi.org/10.1007/s40274-018-4971-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4971-6